Actively Recruiting

Age: 18Years +
All Genders
NCT06059053

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

Led by University Hospital Muenster · Updated on 2024-03-26

100

Participants Needed

1

Research Sites

167 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.

CONDITIONS

Official Title

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Presence of pararenal or thoracoabdominal aortic pathology
  • Treatment planned with a semibranch device branch from Artivion
  • Availability of the patient during the follow-up period
  • Patient informed about the study and provides written informed consent
Not Eligible

You will not qualify if you...

  • Women of childbearing age
  • Patients under 18 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Muenster University Hospital

Münster, Germany

Actively Recruiting

Loading map...

Research Team

A

Alexander Oberhuber, MD,PhD

CONTACT

V

vascular trial unit

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry. | DecenTrialz